The University of Texas Medical School at Houston Department of Psychiatry & Behavioral Sciences
Department of Psychiatry and Behavioral Sciences
The Department of Psychiatry and Behavioral Sciences

Treatment Research Clinic

 


Selected Publications

  1. Schmitz J.M., Lindsay J.A., Stotts A.L., Green C.E., Moeller F.G. Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets. Exp Clin Psychopharmacol. 2012 Jun; 18(3):238-44.
  2. Rogers R.D., Moeller F.G., Swann A.C., Clark L. Recent research on impulsivity in individuals with drug use and mental health disorders: implications for alcoholism. Alcohol Clin Exp Res. 2010 Aug; 34(8):1319-33.
  3. Schmitz J.M., Mooney M.E., Green C.E., Lane S.D., Steinberg J.L., Swann A.C., Moeller F.G. Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial.J Addict Dis. 2009 Jul; 28(3):250-7.
  4. Bankston S.M., Caroll D.D., Cron S.G., Granmayeh L.K., Marcus M.T., Moeller F.G., Schmitz J.M., Swank P, Liehr P.R.. Substance abuser impulsivity decreases with a nine-month stay in a therapeutic community. Am J Drug Alcohol Abuse. 2009; 35(6):417-20.
  5. Moller F.G., Kjome K.L., Ma L. Imaging advances in developing new medications for addiction. Neuropsychopharmacology. 2010 Jan; 35(1):339-40.
  6. Schmitz J.M., Lindsay J.A., Green C.E., Herin D.V., Stotts A.L., Moeller F.G. high-dose naltrexone therapy for cocaine-alcohol dependence. Am J Addict. 2009 Sep-Oct; 18(5):356-62.
  7. Brown E.S., Carmody T.J., Schmitz J.M., Caetano R., Adinoff B., Swann A.C., Rush J.A. A randomized, double-blind, placebo-controlled piolt study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res. 2009 Nov; 33(11):1863-9.
  8. Green C.E., Moeller F.G., Schmitz J.M., Lucke J.F., Lane S.D., Swann A.C., Lasky R.E., Carbonari J.P. Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach. Am J Drug Alcohol Abuse. 2009; 35(2):95-102.
  9. Johnson B.A., Rosenthal N., Capece J.A., Wiegand F., Mao L., Beyers K., McKay A., Ait-Daoud N., Addolorato G., Anton R.F., Ciraulo D.A., Kranzler H.R., Mann K., O'Malley S.S., Swift R.M. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Topiramate for Alcohol Advisory Board.; Topiramate for Alcoholism Study Group. Arch Intern Med. 2008 Jun 9; 168(11)1188-99.
  10. SchmitzJ.M., Mooney M.E., Moeller F.G., Stotts A.L., Green C., Grabowski J. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend. 2008 Apr 1; 94(1-3):142-50.
  11. Moeller F.G., Schmitz J.M., Steinberg J.L., Green C.M., Reist C., Lai L.Y., Swann A.C., Grabowki J. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse. 2007; 33(3):367-78.
  12. Mooney M.E., Schmitz A.L., Moeller F.G., Grabowski J. Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized clinical trials. Drug Alcohol Depend. 2007 May 11; 88(2-3):214-23.
  13. Schmitz J.M., Stotts A.L., Sayre S.L., DeLaune K.A., Grabowski J. Bupropion and cognitive-behavioral therapy for smoking cessation in women. Nicotine Tob Res. 2007 Jun; 9(6):699-709.
  14. Schmitz J.M., Stotts A.L., Sayre S.L., DeLaune K.A., Grabowski J. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy. Am J Addict. 2004 Jul-Sep; 13(4):333-41.
  15. Moeller F.G., Dougherty D.M., Barrat E.S., Schmitz J.M., Swann A.C., Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat. 2001 Dec; 21(4):193-8.